Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
2. April 2026
3 min to read

Chest Pain With Subtle But Lifesaving ECG Findings

Overview

This study presents a clinical case highlighting the diagnostic value of hyperacute T waves on electrocardiogram (ECG) for early detection of acute coronary occlusion. A 54-year-old woman presented with classic ischemic symptoms, yet her initial ECG was interpreted as normal by both automated analysis and clinician review. Closer inspection revealed subtle hyperacute T waves in the anterior leads, consistent with acute occlusion of the left anterior descending (LAD) artery. The case underscores how reliance on traditional ST-segment elevation criteria alone may delay recognition of life-threatening myocardial infarction.

Published in: Annals of Emergency Medicine
Published on: 23 March 2026

Background

Timely identification of acute coronary occlusion is critical for initiating reperfusion therapy and improving outcomes. The current paradigm distinguishes ST-segment elevation myocardial infarction (STEMI) from non-STEMI (NSTEMI) based on ECG findings, particularly ST-segment elevation. However, this approach has important limitations: up to 25–30% of NSTEMI patients may have an unrecognized total coronary occlusion, associated with significantly higher mortality.

Hyperacute T waves have emerged as an early and specific ECG marker of occlusion myocardial infarction, often preceding ST elevation. Despite this, they are frequently overlooked due to their subtle appearance and lack of widespread familiarity or objective criteria. Recent work has introduced quantitative methods based on T-wave magnitude and symmetry, but these are not routinely applied in clinical practice.

Methods

This report describes a single-patient case analysis within the “ECG of the Month” educational framework. Clinical presentation, ECG findings, and subsequent clinical course were reviewed. The initial ECG obtained at urgent care was compared with the prior baseline ECG and follow-up ECGs during deterioration.

Key ECG features were analyzed qualitatively and in reference to established criteria for hyperacute T waves, including:

  • Increased T-wave amplitude relative to the QRS complex
  • Symmetric T-wave morphology
  • Changes compared to baseline ECG

Clinical outcomes, including cardiac arrest, angiographic findings, and response to intervention, were documented to correlate ECG findings with definitive diagnosis.

Results

The patient presented with chest pain, nausea, and autonomic symptoms, but her initial ECG was interpreted as normal. Retrospective analysis demonstrated hyperacute T waves in leads V2–V5, with subtle (<1 mm) ST elevation.

Shortly after leaving urgent care, the patient suffered ventricular fibrillation cardiac arrest. Following resuscitation, the repeat ECG showed clear anterior STEMI. Coronary angiography confirmed acute thrombotic occlusion of the mid-LAD, which was treated with stenting. Despite intervention, the patient developed cardiogenic shock requiring advanced mechanical support, with severely reduced left ventricular ejection fraction (10%).

Comparison with baseline ECG revealed increased T-wave symmetry and magnitude, along with reduced QRS amplitude—features consistent with hyperacute T waves (illustrated on page 2).

Conclusion

This case demonstrates that hyperacute T waves can serve as an early and highly specific indicator of acute coronary occlusion, even in the absence of diagnostic ST-segment elevation. Failure to recognize these subtle ECG findings may delay life-saving treatment and worsen clinical outcomes. Greater awareness and education regarding hyperacute T waves—along with potential integration of automated or AI-based detection tools—may improve early diagnosis, guide urgent reperfusion decisions, and ultimately reduce morbidity and mortality in patients with acute coronary syndromes.

Chest Pain With Subtle But Lifesaving ECG Findings
Authors: Rachael S. Hamm, MDa; H. Pendell Meyers, MDa; Stephen W. Smith, MDb

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

Can an AI ECG algorithm improve diagnostic accuracy for acute coronary occlusion in the difficult subset of canceled catheterization lab activations?

Discordance in ECG interpretation between Emergency Medicine and Cardiology teams is common, and within canceled STEMI activations, a true acute coronary occlusion myocardial infarction (OMI) can go unrecognized. This retrospective study examined whether an AI ECG algorithm (Queen of Hearts™) could improve OMI detection in this difficult subset. Across three referral centers, the investigators analyzed 185 activations canceled for not meeting STEMI criteria, of which 17 met the definition of a missed OMI. The AI algorithm identified 16 of 17 cases, far exceeding STEMI criteria in sensitivity (94.1% vs. 47.1%), supporting its use as an adjunct to clinical judgment in ambiguous cases.

Artificial Intelligence-Assisted, ECG-Based Triage of Patients With Chest Pain to Immediate Invasive Treatment

Rapid identification of acute coronary occlusion (ACO) is critical in chest pain patients, yet conventional STEMI criteria miss occlusion in many NSTEMI cases, delaying life-saving invasive treatment. This retrospective study tested whether a deep learning ECG AI model could improve ACO detection in an unselected cohort of more than 4,000 consecutive patients from a German chest pain unit. Each 12-lead ECG was assessed using both standard STEMI criteria and the AI model, with ACO independently adjudicated by a blinded physician. The AI model clearly outperformed STEMI criteria, identifying 73 of 104 ACO cases versus 30 (area under the curve 0.958 vs. 0.589), with fewer false positives. The findings suggest AI-assisted ECG interpretation can detect subtle ischemic changes beyond established criteria and support faster triage of NSTE-ACO patients to immediate invasive care.

Join over 100,000 healthcare professionals who are already taking advantage of AI